(E/Z) -BCI

• Description:

  (E/Z) -BCI attenuates LPS-induced inflammatory mediators and ROS production in macrophage cells via activating the Nrf2 signaling axis and inhibiting the NF-κB pathway. (E/Z) -BCI is a dual-specificity phosphatase 6 (DUSP6) inhibitor with anti-inflammatory activities.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  317.432

• Molecular Formula:

  C22H23NO

• Notes:

  Research use only, not for human use.

• Receptor:

  PEGs

• CAS Number:

  15982-84-0